Wells Fargo & Company Issues Pessimistic Forecast for GeneDx (NASDAQ:WGS) Stock Price
GeneDx (NASDAQ:WGS – Get Free Report) had its price objective cut by investment analysts at Wells Fargo & Company from $105.00 to $78.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 16.02% […]
GeneDx (NASDAQ:WGS – Get Free Report) had its price objective cut by investment analysts at Wells Fargo & Company from $105.00 to $78.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 16.02% […]
